Table 4. Univariate Cox regression for influence of baseline plasma metabolites on 60-day mortality.
| Metabolite | HR* | 95% CI* | p-value | FDR† |
|---|---|---|---|---|
| Tryptophan | 0.8 | 0.56, 1.16 | 0.2 | 0.4 |
| Kynurenine | 1.54 | 1.22, 1.93 | <0.001 | 0.002 |
| Kynurenic acid | 1.2 | 1.01, 1.43 | 0.036 | 0.2 |
| 3-Hydroxyanthranilic acid | 1.13 | 1.00, 1.28 | 0.045 | 0.2 |
| Xanthurenic acid | 1.11 | 0.98, 1.25 | 0.1 | 0.3 |
| Quinolinic acid | 0.99 | 0.88, 1.12 | 0.9 | 0.9 |
| Niacinamide | 0.92 | 0.79, 1.07 | 0.3 | 0.4 |
| 3-Indoleacetic acid | 1.04 | 0.97, 1.12 | 0.3 | 0.4 |
| N-Acetylserotonin | 1.05 | 0.91, 1.22 | 0.5 | 0.6 |
| 5-Methoxytryptophol | 1.04 | 0.85, 1.28 | 0.7 | 0.8 |
Baseline plasma tryptophan metabolites were measured in a subset 300 patients. Cox regression models were stratified by sites and adjusted by age, sex, and GCS. Bold: False Discovery Rate (FDR) < 0.05.
HR = hazard ratio, CI = confidence interval.
Benjamini and Hochberg correction for multiple testing.